Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
47.30
+0.22 (0.47%)
At close: Apr 13, 2026, 4:00 PM EDT
46.27
-1.03 (-2.19%)
After-hours: Apr 13, 2026, 5:34 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $3.62 billion as of April 13, 2026. Its market cap has increased by 118.95% in one year.
Market Cap
3.62B
Enterprise Value
3.22B
1-Year Change
118.95%
Ranking
Category
Stock Price
$47.30
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.62B, an increase of 283.84%. That is a compound annual growth rate of 18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.60B | 15.25% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.55B |
| Lantheus Holdings | 5.24B |
| Hims & Hers Health | 4.43B |
| Amneal Pharmaceuticals | 4.00B |
| Liquidia | 3.40B |
| Supernus Pharmaceuticals | 2.92B |
| Prestige Consumer Healthcare | 2.68B |
| HUTCHMED (China) | 2.55B |